» Articles » PMID: 12854626

Bacterial Infections in Patients Requiring Admission for an Acute Exacerbation of COPD; a 1-year Prospective Study

Overview
Journal Respir Med
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2003 Jul 12
PMID 12854626
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objective: To investigate the frequency of respiratory bacterial infections in hospitalized patients, admitted with an acute exacerbation of chronic obstructive pulmonary disease (COPD), to identify the responsible pathogens by sputum culture and to assess patient characteristics in relation to sputum culture results.

Methods: We prospectively evaluated clinical data and sputum culture results of 171 patients, admitted to the pulmonology department of the University Hospital Maastricht with an acute exacerbation of COPD from 1st January 1999 until 31st December 1999.

Results: Eighty-five patients (50%) had positive sputum cultures, indicating the presence of bacterial infection. Pathogens most frequently isolated were: Haemophilus influenzae (45%), Streptococcus pneumoniae (27%), and Pseudomonas aeruginosa (15%). Patients with more severely compromised lung function had a higher incidence of bacterial infections (P = 0.026). There were no significant differences in age, lung function parameters, blood gas results and length of hospital stay between patients with and without bacterial infection. There were no correlations between the type of bacteria isolated and clinical characteristics.

Conclusion: Incidence of bacterial infection during acute exacerbations of COPD is about 50%. Patients with and without bacterial infection are not different in clinical characteristics or in outcome parameters. Patients with lower FEV1 have a higher incidence of bacterial infections, but there is no difference in the type of bacterial infection. In the future, the pathogenic role of bacterial infection in exacerbations of COPD should be further investigated, especially the role of bacterial infection in relation to local and systemic inflammation.

Citing Articles

Molecular basis for the transcriptional regulation of an epoxide-based virulence circuit in Pseudomonas aeruginosa.

He S, Taher N, Simard A, Hvorecny K, Ragusa M, Bahl C Nucleic Acids Res. 2024; 52(20):12727-12747.

PMID: 39413156 PMC: 11648964. DOI: 10.1093/nar/gkae889.


Systemic antibiotics for Pseudomonas aeruginosa infection in outpatients with non-hospitalised exacerbations of pre-existing lung diseases: a randomised clinical trial.

Eklof J, Alispahic I, Armbruster K, Lapperre T, Browatzki A, Overgaard R Respir Res. 2024; 25(1):236.

PMID: 38844921 PMC: 11157704. DOI: 10.1186/s12931-024-02860-9.


Molecular basis for the transcriptional regulation of an epoxide-based virulence circuit in .

He S, Taher N, Hvorecny K, Ragusa M, Bahl C, Hickman A bioRxiv. 2024; .

PMID: 38293063 PMC: 10827105. DOI: 10.1101/2024.01.16.572601.


Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study.

Ullah M, Parthasarathi A, Siddaiah J, Vishwanath P, Upadhyay S, Ganguly K Toxics. 2022; 10(11).

PMID: 36355958 PMC: 9695923. DOI: 10.3390/toxics10110667.


Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and....

Eklof J, Alispahic I, Sivapalan P, Wilcke T, Seersholm N, Armbruster K Trials. 2022; 23(1):817.

PMID: 36167555 PMC: 9513970. DOI: 10.1186/s13063-022-06720-z.